Alzheimer's Drug Insights

Jason discusses the recent advancements in testing cerebrospinal fluid to measure amyloid and tau proteins, providing clearer diagnoses for Alzheimer's. He explains how patients in early stages may not notice a significant change, but the drugs can effectively slow the progression of cognitive decline, extending their ability to engage in daily activities.